Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: J Cyst Fibros. 2023 Nov 25;23(1):161–164. doi: 10.1016/j.jcf.2023.11.008

Table 2.

, Respiratory symptoms averages over 24 months

Whole Cohort ETI Non-ETI
CFRSD-CRISS (Higher=Worse)

Difficulty Breathing 1.0 0.7 1.3
Feverish 0.2 0.1 0.3
Fatigue 1.4 1.2 1.6
Chills/Sweats 0.2 0.1 0.3
Increased Cough 1.1 0.8 1.4
Increased Mucus 1.4 1.0 1.7
Chest Tightness 0.9 0.6 1.1
Wheezing 0.6 0.4 0.7
Total CRISS Score 36.7 30.8 42.5
  Women 42.6 37.2 46.8
  Men 32.6 27.8 37.4

CFQ-R Respiratory (Lower=Worse)

Congestion 2.7 3.0 2.4
Increased Cough 2.4 2.8 2.1
Increased Mucus 2.5 2.9 2.3
Wheezing 3.2 3.3 3.0
Difficulty Breathing 3.0 3.3 2.8
Woken up at night d/t 3.2 3.6 3.0
coughing

Total Respiratory 60.4 70.0 50.7
Score
  Women 53.3 62 44.6
  Men 65.7 74.4 57